Trademark applications and grants for Santhera Pharmaceuticals Schweiz G M B H. Santhera Pharmaceuticals Schweiz G M B H has 5 trademark applications. The latest application filed is for "RAXONE"
Patent Application | Date |
---|---|
Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Muscular Dystrophies 20090012050 - 11/886388 Meier; Thomas ;   et al. | 2009-01-08 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "RAXONE" 3255290 78804242 |
RAXONE 2006-02-01 |
![]() "MOTEC" 78804257 |
MOTEC 2006-02-01 |
![]() "DEDOXA" 3669437 78804270 |
DEDOXA 2006-02-01 |
![]() "CARDIBENONE" 78406336 |
CARDIBENONE 2004-04-22 |
![]() "MYOBENONE" 3078478 78320752 |
MYOBENONE 2003-10-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.